Skip to main content

Company News

  • April 15, 2024

    bioMérieux Named Business of the Year by Utah Governor’s Office of Economic Opportunity

    bioMérieux, a world leader in the field of in vitro diagnostics, has received the 2024 Business of the Year Award, presented by the Utah Governor’s Office of Economic Opportunity at One Utah Summit April 11-12, in Salt Lake City.
  • January 18, 2024

    bioMérieux and the University of Pittsburgh Form Research Partnership

    A strategic R&D partnership between bioMérieux and the University of Pittsburgh (Pitt) has been launched, paving the way for many innovative and collaborative research projects.
  • December 18, 2023

    CATTI and bioMérieux Canada are joining forces to support the development of a qualified workforce in advanced therapies

    CATTI, Canadian Advanced Therapies Training Institute, and bioMérieux Canada are combining their respective strengths to enhance the training of the workforce in advanced therapies and the production of quality control solutions (for the pharmaceutical industries).
  • December 13, 2023

    bioMérieux celebrates the First Graduating Class of its Academy of microbiology in Latin America

    In 2020, bioMérieux launched an innovative educational program in Latin America dedicated to healthcare professionals to strenghten their understanding and practice of microbiology.
  • November 28, 2023

    A Stronger Business Relationship to Enhance bioMérieux’s BIOFIRE® SPOTFIRE® Presence in the US Outpatient Diagnostic Market

    bioMérieux has strengthened its relationship with McKesson Medical-Surgical, a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.